In CRC patients, the reproducibility of the EORTC QLQ-C30 questionnaires is good or excellent except for nausea/vomiting subscale (which can be explained by changes in the symptom intensity and changes in antiemetic treatment) and surprisingly for QoL/GHS questionnaire. The reproducibility of QLQ-CR...
n ICCa 95% CIb EORTC QLQ-C30: Functional scales: Physical function 34 0.87 0.76-0.93 Role function 33 0.80 0.64-0.90 Emotional function 34 0.73 0.52-0.85 Cognitive function 34 0.79 0.62-0.89 Social function 34 0.84 0.71-0.92 Global QoL/GHS 34 0.33 -0.01-0.59 Sympt...
using a mixed-effects growth curve model; mixed-effects models for repeated measurements (MMRM); time-to-deterioration (TTD); status change; and responder analysis) were used to analyze EORTC QLQ-C30 global health status (GHS)/QoL and scores from functional scales.Overall, GHS/QoL and physical...
The aim of the present study is to develop direct and indirect mapping algorithms from EORTC QLQ-C30 and FACT-G onto the EQ-5D-5L index using data from the Quality Of Life Mapping Algorithm for Cancer (QOL- MAC) study, where EQ-5D-5L, EORTC QLQ-C30, and FACT-G data are cross-...
Methods: We conducted the QOL-MAC study where EQ-5D-5L, EORTC QLQ-C30, and FACT-G were cross-sectionally evaluated in patients receiving drug treatment for solid tumors in Japan. We developed direct and indirect mapping algorithms using 7 regression methods. Direct mapping was based on ...